The Role of Hyperglycemia in the Perioperative Period in Carrying out Aortocoronary Shunting
Abstract
In this article we presented pathophysiological features of hyperglycemia and its negative effects on the cardiovascular system, the ways to achieve optimal perioperative glycemic control, as well as the results of studies aimed to determine the optimal level of blood glucose for preventing postoperative complications and achieving optimal clinical results.
About the Authors
R. R. Yarbekov
FSGE “Scientific centre of cardiovascular surgery named after A.N. Bakulev
Russian Federation
Russian Federation
Yarbekov Rustam Raimkulovich – cand. med. sciences, doctoral candidate
A. A. Nazarov
FSGE “Scientific centre of cardiovascular surgery named after A.N. Bakulev
Russian Federation
Russian Federation
Nazarov Afanasiy Anatolievich – postgraduate student
References
1. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery) / K.A. Eagle, R.A. Guyton, R. Davidoff [et al.] // Circulation. – 2004. – №110. – P. 340-437.
2. American association of clinical endocrinologists and american diabetes association consensus statement on inpatient glycemic control / S. Moghissi, M.T. Korytkowski, M. DiNardo [et al.] // Endocrine Practice. – 2009. – №15. – V4. – P. 353-369.
3. Are even impaired fasting blood glucose levels preoperatively associated with increased mortality after CABG surgery? / R.E. Anderson, K. Klerdal, T. Ivert [et al.] // European Heart Journal. – 2005. – №26. – V15. – P. 1513-1518.
4. Circulating adhesion molecules in humans: role of hyperglycemia and hyperinsulinemia / R. Marfella, K. Esposito, R. Gionata [et al.] // Circulation. – 2000. – №201. – P. 2247-2251.
5. Coronary artery bypass grafting in type II diabetic patients: a comparison between insulindependent and non-insulin-dependent patients at short- and mid-term follow-up / N. Luciani, G. Nasso, M. Gaudino [et al.] // Annals of Thoracic Surgery. – 2003. – №76. – V4. – P. 1149-1154.
6. Development and validation of a prediction model for strokes after coronary artery bypass grafting / C. Charlesworth, D.S. Likosky, C.A.S. Marrin [et al.] // Annals of Thoracic Surgery. – 2003. – №76. – V2. – Р. 436-443.
7. Effects of aggressive vs moderate glycemic control on clinical outcomes in diabetic coronary artery bypass graft patients / H.L. Lazar, M.M. McDonnell, S. Chipkin [et al.] // Annals of Surgery. – 2011. – №254. – V3. – P. 458-64.
8. Effect of diabetes and associated conditions on long-term survival after coronary artery bypass graft surgery / B.J. Leavitt, L. Sheppard, C. Maloney [et al.] // Circulation. – 2004. – №1101. – P. II41-II44.
9. Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery / C. Kubal, A.K. Srinivasan, A.D. Grayson [et al.] // Annals of Thoracic Surgery. – 2005. – №79. – P. 1570-1576.
10. Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus / B. Guerci, P. Bohme, A. Kearney-Schwartz [et al.] // Diabetes and Metabolism. – 2001. – №27. – V41. – P. 436-47.
11. Expression of inducible nitric oxide synthase in conduits used in patients with diabetes mellitus undergoing coronary revascularization / H.L. Lazar, L. Joseph, C. San Mateo [et al.] // Journal of Cardiac Surgery. – 2010. – №25. – P. 120-126.
12. Glucose measurement: confounding issues in setting targets for inpatient management / K. Dungan, J. Chapman, S.S. Braithwaite [et al.] // Diabetes Care. – 2007. – №30. – V2. – P. 403- 409.
13. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post¬ishemic hearts by inhibiting glucose oxidation / L.J.C. Docherty, J.C.T. Rendell, A.S. Clanachan [et al.] // Journal of the American College of Cardiology. – 2002. – №39. – V4. – Р. 718-725.
14. Krikorian A. Comparisons of different insulin infusion protocols: a review of recent literature / A. Krikorian, F. Ismail-Beigi, E.S. Moghissi // Current Opinion in Clinical Nutrition and Metabolic Care. – 2010. – №13. – V2. – P. 198- 204.
15. Lazar H.L. Glycemic Control during Coronary Artery Bypass Graft Surgery / H.L. Lazar // ISRN Cardiol. – 2012; 292490.
16. Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery / T. Doenst, D. Wijeysundera, K. Karkouti [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2005. – №130. – V4. – P. 1144.el-l 144.e8.
17. Impact of admission serum glucose level on in-hospital outcomes following coronary artery bypass grafting surgery / S.A. Imran, T. P.P. Ransom, K.J. Buth [et al.] // Canadian Journal of Cardiology. – 2010. – №26. – V3. – P. 151—154.
18. Impact of hyperglycemia on perioperative mortality after coronary artery bypass graft surgery / J. Szekely, J. Levin, Y. Miao [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2011. – №142. – V2. – P. 430-437.
19. Insulin absorption: a major factor in apparent insulin resistance and the control of type 2 diabetes mellitus / S.J. Friedberg, Y.W. Lam, J.J. Blum [et al.] // Metabolism. – 2006. – №55. – V5. – P. 614-619.
20. Insulin attenuates the systemic inflammatory response in endotoxemic rats / M.G. Jeschke, D. Klein, U. Bolder [et al.] // Endocrinology. – 2004. – №145. – V9. – P. 4084-4093.
21. Insulin stimulates pyruvate dehydrogenase and protects human ventricular cardiomyocytes from simulated ischemia / V. Rao, F. Merante, R.D. Weisel [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 1998. – №116. – V3. – P. 485-94.
22. Intensive insulin therapy protects the endothelium of critically ill patients / L. Langovche, I. Vanhorebeek, D. Vlaselaers [et al.] // The Journal of Clinical Investigation. – 2005. – №115. – P. 1177-1186.
23. London M. J. Association of fasttrack cardiac management and low-dose to moderate-dose glucocorticoid administration with perioperative hyperglycemia / M.J. London, M.J. Grunwald, A.L.W. Shroyer // Journal of Cardiothoracic and Vascular Anesthesia. – 2000. – №14. – V6. – P. 631-638.
24. Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemiareperfusion: the roles of PI3-kinase, Akt, and endothelial nitric oxide synthase phosphorylation / F. Gao, E. Gao, T.L. Yue [et al.] // Circulation. – 2002. – №105. – V12. – P. 1497-1502.
25. Outcomes and perioperative hyperglycemia in patients with or without diabetes mellitus undergoing coronary artery bypass grafting / C.A. Estrada, J.A. Young, L.W. Nifong [et al.] // Annals of Thoracic Surgery. – 2003. – №75. –V.5. – P.1392-1399.
26. Prevalence of the metabolic syndrome in patients with coronary heart disease, cerebrovascular disease, peripheral arterial disease or abdominal aortic aneurysm / P.M. Gorter, J.K. Olijhoek, Y. Van der Graaf [et al.] // Atherosclerosis. – 2004. – №173. – P. 363-369.
27. Reliability of point-of-care testing for glucose measurement in critically ill adults / J. Kanji, J. Buffie, B. Hutton [et al.] // Critical Care Medicine. – 2005. – №3. –V.3-12. – P. 2778-2785.
28. Safety and efficacy of continuous insulin infusion in noncritical care settings / L. Smiley, M. Rhee, L. Peng [et al.] // Journal of Hospital Medicine. – 2010. – №5. – V4. – P. 212-217.
29. Safety and effectiveness of a standardized 80-150 mg/dl iv insulin infusion protocol in the Medical Intensive Care Unit: >11, 000 hours of experience / E. Donihi, R. Rea, L. Haas [et al.] // Diabetes. – 2006. – №55. – Р. 459.
30. Sowers J.R. Diabetes mellitus and associated hypertension, vascular disease, and nephropathy / J.R. Sowers, M. Epstein // Hypertension. – 1995. – №26. – V6. – P. 869-879.
31. Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting / M. Bhamidipati, D. J. Lapar, G. J. Stukenborg [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 2011. – №141. – V2. – P. 543–551.
32. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes / The International Expert Committee // Diabetes Care. – 2009. – №7. – P. 1327-1334.
33. The Society of Thoracic Surgeons Practice Guideline Series: blood glucose management during adult cardiac surgery / H.L. Lazar, M. McDonnell, S.R. Chipkin [et al.] // Annals of Thoracic Surgery. – 2009. – №87. – V2. – P. 663- 669.
34. Trauma metabolism and the heart. Uptake of substrates and effects of insulin early after cardiac operations / S. Svensson, R. Svedjeholm, R. Ekroth [et al.] // Journal of Thoracic and Cardiovascular Surgery. – 1990. – №99. – V6. – P. 1063-1073.
35. Use of intensive insulin therapy for the management of glycemic control in hospitalized patients: a clinical practice guideline from the American College of Physicians / L.L. Qaseem, R. Humphrey, V. Chou [et al.] // Annals of Internal Medicine. – 2011. – №154. – V4. – P. 260-267.
36. Value of postoperative blood glucose in predicting complications and length of stay after coronary artery bypass grafting / L.H. Fish, T.W. Weaver, A.L. Moore [et al.] // American Journal of Cardiology. – 2003; -№92. – V1. – P. 74-76.
37. Vlassara H. Recent progress in advanced glycation end products and diabetic complications / H. Vlassara // Diabetes. – 1997. – №46. – V2. – P. S19-S25.
Review
For citations:
Yarbekov R.R., Nazarov A.A. The Role of Hyperglycemia in the Perioperative Period in Carrying out Aortocoronary Shunting. Yakut Medical Journal. 2015;(1):56-60.
Views:
9
Email this article 